121 related articles for article (PubMed ID: 34034413)
1. [Study on the expression of microRNA-1825 in serum of pre-operative and post-operative patients with breast cancer].
He YY; Xiao B; Qiu JH; Lei T; Li LH; Sun ZH
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 May; 55(5):691-697. PubMed ID: 34034413
[TBL] [Abstract][Full Text] [Related]
2. Serum microRNA-155 as a potential biomarker to track disease in breast cancer.
Sun Y; Wang M; Lin G; Sun S; Li X; Qi J; Li J
PLoS One; 2012; 7(10):e47003. PubMed ID: 23071695
[TBL] [Abstract][Full Text] [Related]
3. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
[TBL] [Abstract][Full Text] [Related]
4. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
Liu W; Xu Y; Guan H; Meng H
Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
Orangi E; Motovali-Bashi M
Gene; 2019 Mar; 687():272-279. PubMed ID: 30468908
[TBL] [Abstract][Full Text] [Related]
6. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Significance of sICAM-1 in Differentiating Benign Breast Lesions from Breast Cancer.
Chen C; Chen Q; Dong Y; Liu X
Ann Clin Lab Sci; 2020 Sep; 50(5):650-656. PubMed ID: 33067211
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA-21 as a prognostic, biological marker in cholangiocarcinoma.
Liu CH; Huang Q; Jin ZY; Xie F; Zhu CL; Liu Z; Wang C
J Cancer Res Ther; 2018 Jan; 14(1):220-225. PubMed ID: 29516989
[TBL] [Abstract][Full Text] [Related]
9. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
10. Expression levels and clinical values of miR-92b-3p in breast cancer.
Du Y; Miao Z; Wang K; Lv Y; Qiu L; Guo L
World J Surg Oncol; 2021 Aug; 19(1):239. PubMed ID: 34380511
[TBL] [Abstract][Full Text] [Related]
11. Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer.
Tan Z; Zou Y; Zhu M; Luo Z; Wu T; Zheng C; Xie A; Wang H; Fang S; Liu S; Li Y; Lu Z
BMC Cancer; 2021 Apr; 21(1):409. PubMed ID: 33858374
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.
Le HB; Zhu WY; Chen DD; He JY; Huang YY; Liu XG; Zhang YK
Med Oncol; 2012 Dec; 29(5):3190-7. PubMed ID: 22782668
[TBL] [Abstract][Full Text] [Related]
13. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
14. [Value of the concentration and integrity of serum cell-free DNA for the clinical diagnosis of esophageal carcinoma].
Qiu YW; Shen XJ; Jin CJ; Cao XJ; Ju SQ
Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):905-910. PubMed ID: 30605980
[No Abstract] [Full Text] [Related]
15. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
16. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
Motawi TM; Sadik NA; Shaker OG; El Masry MR; Mohareb F
Gene; 2016 Sep; 590(2):210-9. PubMed ID: 26827795
[TBL] [Abstract][Full Text] [Related]
17. Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses.
Park BJ; Cha MK; Kim IH
BMC Res Notes; 2014 Jan; 7():7. PubMed ID: 24393391
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between expression of microRNA and inflammatory cytokines plasma level in pediatric patients with sepsis].
Wu Y; Li C; He Y; Li Q; Wang G; Wen P; Yang W; Yang Y
Zhonghua Er Ke Za Zhi; 2014 Jan; 52(1):28-33. PubMed ID: 24680405
[TBL] [Abstract][Full Text] [Related]
19. Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer.
Wang Q; Zhang H; Shen X; Ju S
Ann Clin Biochem; 2017 Jan; 54(1):76-85. PubMed ID: 27126269
[TBL] [Abstract][Full Text] [Related]
20. Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer.
Zhao FL; Dou YC; Wang XF; Han DC; Lv ZG; Ge SL; Zhang YK
Mol Biol Rep; 2014 Sep; 41(9):5913-22. PubMed ID: 25103018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
